Amplifying the Red-Emission of Upconverting Nanoparticles for Biocompatible Clinically Used Prodrug-Induced Photodynamic Therapy
Open Access
- 25 September 2014
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 8 (10) , 10621-10630
Abstract
A class of biocompatible upconverting nanoparticles (UCNPs) with largely amplified red-emissions was developed. The optimal UCNP shows a high absolute upconversion quantum yield of 3.2% in red-emission, which is 15-fold stronger than the known optimal β-phase core/shell UCNPs. When conjugated to aminolevulinic acid, a clinically used photodynamic therapy (PDT) prodrug, significant PDT effect in tumor was demonstrated in a deep-tissue (>1.2 cm) setting in vivo at a biocompatible laser power density. Furthermore, we show that our UCNP–PDT system with NIR irradiation outperforms clinically used red light irradiation in a deep tumor setting in vivo. This study marks a major step forward in photodynamic therapy utilizing UCNPs to effectively access deep-set tumors. It also provides an opportunity for the wide application of upconverting red radiation in photonics and biophotonics.Keywords
Funding Information
- National Institute of Mental Health (R01MH103133)
- University of Massachusetts Medical School, University of Massachusetts
- Human Frontier Science Program (RGY0090/2014)
This publication has 46 references indexed in Scilit:
- Stem Cell Labeling using Polyethylenimine Conjugated (α-NaYbF4:Tm3+)/CaF2 Upconversion NanoparticlesTheranostics, 2013
- Red‐Emitting Upconverting Nanoparticles for Photodynamic Therapy in Cancer Cells Under Near‐Infrared ExcitationSmall, 2012
- Tuning upconversion through energy migration in core–shell nanoparticlesNature Materials, 2011
- Pegylated Composite Nanoparticles Containing Upconverting Phosphors and meso‐Tetraphenyl porphine (TPP) for Photodynamic TherapyAdvanced Functional Materials, 2011
- Absolute quantum yield measurements of colloidal NaYF4: Er3+, Yb3+ upconverting nanoparticlesNanoscale, 2010
- Upconversion nanoparticles in biological labeling, imaging, and therapyThe Analyst, 2010
- Mesoporous‐Silica‐Coated Up‐Conversion Fluorescent Nanoparticles for Photodynamic TherapySmall, 2009
- Phase I clinical trial of the use of zinc phthalocyanine tetrasulfonate as a photosensitizer for photodynamic therapy in dogsAmerican Journal of Veterinary Research, 2007
- Hexagonal Sodium Yttrium Fluoride Based Green and Blue Emitting Upconversion PhosphorsChemistry of Materials, 2004
- Photodynamic therapy for cancerNature Reviews Cancer, 2003